In human breast cancer, miR-155 levels were positively correlated with the presence of CD8+ T cells and M1 macrophages in the tumor microenvironment (TME), making it a fair case for exploring the importance of miR-155 in cancer immune regulation and its potential in cancer immunotherapy (7). This evidence concerns the gene CD8A and cancer.